A Renaissance in Pharmacy Education at the University of North Carolina at Chapel Hill
Roth MT, et al. | JANUARY 2014
INVITED COMMENTARY The UNC Eshelman School of Pharmacy is transforming its doctor of pharmacy program to emphasize active engagement of students in the classroom, foster scientific inquiry and innovation, and immerse students in patient care early in their education. The admissions process is also being reengineered.
The Impact of Maltreatment on the Developing Child
Hagele DM | NOVEMBER 2005
INVITED COMMENTARY Child maltreatment represents an extreme traumatic insult to the developing child. Chronic traumatic exposure during childhood may lead to persistent changes in brain structure and chemistry that contribute to long-term dysfunction.
Respiratory Diseases: Meeting the Challenges of Screening, Prevention, and Treatment
Chang LH, Rivera MP | SEPTEMBER 2013
ISSUE BRIEF Respiratory conditions, both acute and chronic, continue to have a significant impact on worldwide health because of their high prevalence, the high disease burden they place on individual health, and their enormous cost to the health care system. There are also unmeasured indirect economic costs due to loss of productivity. Despite advances in our understanding of the complex pathophysiology of respiratory diseases, as well as the availability of relatively straightforward primary prevention measures, the prevalence of chronic respiratory diseases continues to rise. In addition, periodic outbreaks of acute infectious respiratory conditions result in significant cost and even mortality, and the incidence of these conditions fluctuates widely from year to year. Although we have seen recent developments in medical therapies for respiratory diseases, and there are established and well-publicized disease management guidelines, morbidity and mortality remain high. One intervention that has lagged behind has been smoking prevention and cessation, which is the mainstay of prevention for chronic obstructive pulmonary disease and lung cancer. The persistence of these conditions underscores vulnerabilities within our national and regional health care systems. Several of the articles in this issue of the NCMJ describe innovative programs to address these challenges.
Direct-to-Consumer Genomic Testing Offers Little Clinical Utility but Appears to Cause Minimal Harm
Adams SD, et al. | NOVEMBER 2013
INVITED COMMENTARY Direct-to-consumer genomic testing is available to anyone willing to pay for it. We investigated the reliability and reproducibility of such testing by sending DNA samples to 2 popular companies and by reviewing current literature on this topic. The concerns that were initially raised about direct-to-consumer genomic testing still seem valid.